Our next webinar will feature 

Timothy Ziemlewicz, M.D. from the University of Wisconsin presenting:



"Clinical Experience"

The webinar will be held on Thursday, February 19 or Friday, February 20, 2026 depending upon your local time zone.



• 8:00 - 9:00 (West Coast, USA/Canada)
• 11:00 - Noon (East Coast, USA/Canada)
• 16:00 - 17:00 (UK)
• 17:00 - 18:00 (Continental Europe)
• Midnight - 1:00 (China) Friday
• 1:00 - 2:00 (Korea and Japan) Friday

Registration for this event is required. The Webinar Series will be recorded and available to members for later review. Confirmation of your registration and the Zoom Conference Link Info will be emailed to all registered attendees prior to the meeting.

This session will be moderated by George R. Schade, M.D. from the University of Washington.

Timothy Ziemlewicz, M.D.

University of Wisconsin 



Dr. Ziemlewicz is a Professor of Radiology in the section of Abdominal Imaging and Intervention at the University of Wisconsin. He serves as an assistant residency program director, chairs the programs clinical competency committee, and is the medical director of ultrasound. He joined the faculty in 2010 following the completion of an abdominal imaging fellowship at Duke University and diagnostic radiology residency at Wayne State University, Detroit, MI. He spent the early part of his career with a clinical and research focus on thermal tumor ablation and image post-processing for surgical planning. In recent years he has worked closely with the scientists and clinicians who pioneered histotripsy to help advance the technique to clinical adoption. His NIH and industry funded research lab is focused on clinical translation of histotripsy, thermal ablation, and the use of ultrasound for intervention. He has been involved in numerous multi-center clinical trials for thermal ablation and histotripsy, including serving as the co-PI of the #HOPE4LIVER trial which lead to the FDA approval of histotripsy for the treatment of hepatic tumors. In addition to his active thermal ablation and histotripsy practice, he currently educates new users of histotripsy and advises for ongoing clinical trials in the space.

George R. Schade, M.D.

University of Washington 



George R. Schade, MD is an Associate Professor of Urology at the University of Washington. He completed his undergraduate and medical education at the University of Chicago, his Urology Residency at the University of Michigan, and SUO fellowship at the University of Washington. During his residency and fellowship he completed post-doctoral research training in the field of historipsy with Will Roberts, MD and Vera Khohklova, PhD. As a clinician-scientist he leads an R01 funded translational science program aimed at developing therapeutic ultrasound and imaging applications, with emphasis on histotripsy, to reduce the burden of cancer on patients and improve their quality of life. He is the director of the UW Prostate Cancer Focal Therapy Program and member of the West Coast Focal Therapy Collaborative. He is an active user of clinically available therapeutic ultrasound systems using HIFU to treat prostate cancer and investigate clinical outcomes of HIFU. Additionally, he is an active educator training the next generation of clinicians on the benefits of, indications for, and how to perform HIFU. He has been an active participant in ISTU for >10 years and is serving his second term on the ISTU board.

We are so grateful for the sponsorship of this year's Webinar Series. Please learn more about their products and innovations in the field today!

Our January webinar featured Arik Hananel, M.D., MBA, BsCs, CEO and CoFounder from FUSMobile presenting:

"FUS Mobile: The Road to Commercialization"

This session was moderated by Suzanne LeBlang, M.D. from the Focused Ultrasound Foundation.

Registration is Now Open!

Abstract Submissions Due Monday, February 9